BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cheng Y, Desreumaux P. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol 2005; 11(3): 309-314 [PMID: 15637733 DOI: 10.3748/wjg.v11.i3.309]
URL: https://www.wjgnet.com/1007-9327/full/v11/i3/309.htm
Number Citing Articles
1
A. Tursi, G. Brandimarte, W. Elisei, G.M. Giorgetti, C.D. Inchingolo, F. Aiello. Effect of mesalazine on epithelial cell proliferation in colonic diverticular diseaseDigestive and Liver Disease 2008; 40(9): 737 doi: 10.1016/j.dld.2008.02.022
2
Sandra Parenti, Lucia Montorsi, Sebastian Fantini, Fabiana Mammoli, Claudia Gemelli, Claudio Giacinto Atene, Lorena Losi, Chiara Frassineti, Bruno Calabretta, Enrico Tagliafico, Sergio Ferrari, Tommaso Zanocco-Marani, Alexis Grande. KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer CellsCancer Prevention Research 2018; 11(8): 503 doi: 10.1158/1940-6207.CAPR-17-0382
3
Rosivaldo S. Borges, Steven L. Castle. The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activityBioorganic & Medicinal Chemistry Letters 2015; 25(21): 4808 doi: 10.1016/j.bmcl.2015.07.001
4
H. E. Mukaya, E. W. Neuse, R. L. van Zyl, C. T. Chen. Synthesis and Preliminary Bio-evaluation of Polyaspartamide Co-conjugates of p-Amino-salicylic Acid Chelated Platinum(II) and Ferrocene ComplexesJournal of Inorganic and Organometallic Polymers and Materials 2015; 25(3): 367 doi: 10.1007/s10904-015-0174-9
5
Justin A. Maykel, Gonzalo Hagerman, Anders F. Mellgren, Shelby Y. Li, Karim Alavi, Nancy N. Baxter, Robert D. Madoff. Crohn's Colitis: The Incidence of Dysplasia and Adenocarcinoma in Surgical PatientsDiseases of the Colon & Rectum 2006; 49(7): 950 doi: 10.1007/s10350-006-0555-9
6
Richard H. Siggers, David J. Hackam. The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseasesCellular and Molecular Life Sciences 2011; 68(22): 3623 doi: 10.1007/s00018-011-0821-4
7
Dawn M. Torres, Stephen A. Harrison. Hepatitis C, insulin resistance, and steatosisCurrent Hepatitis Reports 2007; 6(4): 129 doi: 10.1007/s11901-007-0015-6
8
Jyothi S. Prabhu, Aruna Korlimarla, Arindam Banerjee, Shivangi Wani, K Payal, Rashmita Sahoo. Gene-Specific Methylation: Potential Markers for Colorectal CancerThe International Journal of Biological Markers 2009; 24(1): 57 doi: 10.1177/172460080902400109
9
Jeffrey Tang, Omar Sharif, Chetan Pai, Ann L. Silverman. Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel DiseaseDigestive Diseases and Sciences 2010; 55(6): 1696 doi: 10.1007/s10620-009-0942-x
10
Rosa Ana Risques, Lisa A. Lai, Cigdem Himmetoglu, Anoosheh Ebaee, Lin Li, Ziding Feng, Mary P. Bronner, Bassel Al-Lahham, Kris V. Kowdley, Keith D. Lindor, Peter S. Rabinovitch, Teresa A. Brentnall. Ulcerative Colitis–Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and InflammationCancer Research 2011; 71(5): 1669 doi: 10.1158/0008-5472.CAN-10-1966
11
Michael Quante, Julian A. Abrams, Yoomi Lee, Timothy C. Wang. Barrett esophagusCell Cycle 2012; 11(23): 4328 doi: 10.4161/cc.22485
12
Chunyi Wang, Zhongxue Fu. The study of RNAi-mediated by conditionally replicating adenovirus silencing on Survivin gene in colon cancer cell lastinglyThe Chinese-German Journal of Clinical Oncology 2008; 7(8): 460 doi: 10.1007/s10330-008-0061-8
13
Pamela M. OʼConnor, Tamia K. Lapointe, Paul L. Beck, Andre G. Buret. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel diseaseInflammatory Bowel Diseases 2010; 16(8): 1411 doi: 10.1002/ibd.21217
14
Lorne J. Hofseth, Lei Ying. Identifying and defusing weapons of mass inflammation in carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2006; 1765(1): 74 doi: 10.1016/j.bbcan.2005.08.005
15
Peter Laszlo Lakatos, Laszlo Lakatos. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategiesWorld Journal of Gastroenterology 2008; 14(25): 3937-3947 doi: 10.3748/wjg.14.3937
16
Vikrant Sibartie, Brian Feagan. Clinical Dilemmas in Inflammatory Bowel Disease2006; : 25 doi: 10.1002/9780470750827.ch8
17
Tae Kyung Ha, Ji Yeong An, Ho Geun Youn, Jae Hyung Noh, Tae Sung Sohn, Sung Kim. Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric CancerYonsei Medical Journal 2007; 48(6): 981 doi: 10.3349/ymj.2007.48.6.981
18
Tomomitsu Tahara, Tomoyuki Shibata, Masaaki Okubo, Tomohiko Kawamura, Noriyuki Horiguchi, Takamitsu Ishizuka, Naoko Nakano, Mitsuo Nagasaka, Yoshihito Nakagawa, Naoki Ohmiya. Demonstration of potential link between Helicobacter pylori related promoter CpG island methylation and telomere shortening in human gastric mucosaOncotarget 2016; 7(28): 43989 doi: 10.18632/oncotarget.9764
19
Muhammad Y. Sheikh. Steatosis in hepatitis C: Mechanisms and basic conceptsCurrent Hepatitis Reports 2008; 7(4): 152 doi: 10.1007/s11901-008-0030-2
20
Lauriane Onfroy-Roy, Dimitri Hamel, Laurent Malaquin, Audrey Ferrand. Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?Cancers 2021; 13(8): 1749 doi: 10.3390/cancers13081749
21
S. PARENTI, F. FERRARINI, R. ZINI, M. MONTANARI, L. LOSI, B. CANOVI, S. FERRARI, A. GRANDE. Mesalazine inhibits the β‐catenin signalling pathway acting through the upregulation of μ‐protocadherin gene in colo‐rectal cancer cellsAlimentary Pharmacology & Therapeutics 2010; 31(1): 108 doi: 10.1111/j.1365-2036.2009.04149.x
22
Hajjaj H.M. Abdu-Allah, Samia G. Abdel-Moty, Raafat El-Awady, Abdel-Nasser A. El-Shorbagi. Design and synthesis of novel 5-aminosalicylate (5-ASA)–4-thiazolinone hybrid derivatives with promising antiproliferative activityBioorganic & Medicinal Chemistry Letters 2016; 26(7): 1647 doi: 10.1016/j.bmcl.2016.02.073
23
F. Holzinger, D. Giachino, E. Karamitopoulou-Diamantis, S. Birrer. Unerwarteter, intraoperativer Befund im Bereiche des distalen ÖsophagusDer Chirurg 2007; 78(6): 548 doi: 10.1007/s00104-006-1248-6
24
Ad A van Bodegraven, Chris JJ Mulder. Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete?World Journal of Gastroenterology 2006; 12(38): 6115-6123 doi: 10.3748/wjg.v12.i38.6115
25
Tomomitsu Tahara, Tomoyuki Shibata, Tomohiko Kawamura, Takamitsu Ishizuka, Masaaki Okubo, Mitsuo Nagasaka, Yoshihito Nakagawa, Tomiyasu Arisawa, Naoki Ohmiya, Ichiro Hirata. Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID useClinical and Experimental Medicine 2016; 16(1): 65 doi: 10.1007/s10238-014-0335-0
26
Wiley Handbook of Current and Emerging Drug Therapies2006;  doi: 10.1002/9780470041000.cedt019
27
Vijay L. Kumar, Sneh Verma, Prasenjit Das. Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancerDrug Development Research 2019; 80(8): 1089 doi: 10.1002/ddr.21590
28
M. Schwab, V. Reynders, S. Loitsch, Y. M. Shastri, D. Steinhilber, O. Schroder, J. Stein. PPAR  is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cellsCarcinogenesis 2008; 29(7): 1407 doi: 10.1093/carcin/bgn118
29
XIAOTAN DOU, JUNHUA XIAO, ZILIANG JIN, PING ZHENG. Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasiaOncology Letters 2015; 10(3): 1259 doi: 10.3892/ol.2015.3397
30
Peri Newman, Joshua Muscat. Potential Role of Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention for Inflammatory Bowel Disease: An Umbrella ReviewCancers 2023; 15(4): 1102 doi: 10.3390/cancers15041102
31
Mariëlle Romberg-Camps, Edith Kuiper, Leo Schouten, Arnold Kester, Martine Hesselink-van de Kruijs, Charles Limonard, Rens Bos, Jelle Goedhard, Wim Hameeteman, Frank Wolters, Maurice Russel, Reinhold Stockbrügger, Pieter Dagnelie. Mortality in inflammatory bowel disease in the Netherlands 1991–2002Inflammatory Bowel Diseases 2010; 16(8): 1397 doi: 10.1002/ibd.21189
32
Roufaida Merir, Milad Baitiche, Zineb Elbahri, Riadh Bourzami, Ferhat Djerboua, Mokhtar Boutahala. Conception of Cellulose/Alginate/Mesalazine microspheres by solvent evaporation technique for drug release: Experimental and theoretical investigationsInternational Journal of Biological Macromolecules 2023; 243: 124894 doi: 10.1016/j.ijbiomac.2023.124894
33
Fumito Saijo, Alexandra B. Milsom, Nathan S. Bryan, Selena M. Bauer, Thorsten Vowinkel, Marina Ivanovic, Chris Andry, D. Neil Granger, Juan Rodriguez, Martin Feelisch. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel diseaseNitric Oxide 2010; 22(2): 155 doi: 10.1016/j.niox.2009.11.009
34
Antonio Tursi, Giovanni Brandimarte, Walter Elisei, Cosimo Damiano Inchingolo, Fabio Aiello. Epithelial Cell Proliferation of the Colonic Mucosa in Different Degrees of Colonic Diverticular DiseaseJournal of Clinical Gastroenterology 2006; 40(4): 306 doi: 10.1097/01.mcg.0000210093.54425.72
35
Christopher D. Jahraus, David T. Rubin, Ellen J. Scherl, Doug Bettenhausen. Inflammation’s Role in Rectal Cancer Following Prostate Radiotherapy, and Emerging Evidence for a Protective Role for BalsalazideGastroenterology 2005; 129(2): 770 doi: 10.1053/j.gastro.2005.06.042
36
Tomomitsu Tahara, Tomoyuki Shibata, Masaaki Okubo, Tomohiko Kawamura, Kazuya Sumi, Takamitsu Ishizuka, Masakatsu Nakamura, Mitsuo Nagasaka, Yoshihito Nakagawa, Naoki Ohmiya, Tomiyasu Arisawa, Ichiro Hirata. Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypesClinical and Experimental Medicine 2015; 15(3): 327 doi: 10.1007/s10238-014-0295-4
37
Shaji Sebastian, Vincent Hernández, Pär Myrelid, Revital Kariv, Epameinondas Tsianos, Murat Toruner, Marc Marti-Gallostra, Antonino Spinelli, Andrea E. van der Meulen-de Jong, Elif Sarıtas Yuksel, Christoph Gasche, Sandro Ardizzone, Silvio Danese. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)Journal of Crohn's and Colitis 2014; 8(1): 5 doi: 10.1016/j.crohns.2013.04.008
38
S Nikolaus, S Schreiber, B Siegmund, B Bokemeyer, E Bästlein, O Bachmann, D Görlich, U Hofmann, M Schwab, W Kruis. Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherenceJournal of Crohn's and Colitis 2017; 11(9): 1052 doi: 10.1093/ecco-jcc/jjx062
39
Mehmet Yalchin, Ann-Marie Baker, Trevor A. Graham, Ailsa Hart. Predicting Colorectal Cancer Occurrence in IBDCancers 2021; 13(12): 2908 doi: 10.3390/cancers13122908
40
Milad Moradi, Elnaz Mazaher Haji Agha, Salar Hemmati, Fleming Martinez, Martin Kuentz, Abolghasem Jouyban. Solubility of 5-aminosalicylic acid in {N-methyl-2-pyrrolidone + ethanol} mixtures at T = (293.2 to 313.2) KJournal of Molecular Liquids 2020; 306: 112774 doi: 10.1016/j.molliq.2020.112774
41
Enzyme Catalyzed Synthesis of Water Soluble Mesalazine Oligomers and Evaluation of their Efficiency in Polypropylene StabilizationPolymer Science, Series B 2021; 63(6): 710 doi: 10.1134/S1560090421060051
42
Yohei Shirakami, Takahiro Kochi, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Kazuto Yoshimi, Takashi Kuramoto, Takuji Tanaka, Masahito Shimizu, Mitsuru Seishima. Inhibitory effects of pentoxifylline on inflammation-related tumorigenesis in rat colonOncotarget 2018; 9(74): 33972 doi: 10.18632/oncotarget.26119
43
S. Viennot, A. Deleporte, D. Moussata, S. Nancey, B. Flourié, J.-M. Reimund. Colon cancer in inflammatory bowel disease: recent trends, questions and answersGastroentérologie Clinique et Biologique 2009; 33: S190 doi: 10.1016/S0399-8320(09)73154-9
44
S. Morini, C. Hassan, A. Zullo, V. De Francesco, O. Burattini, M. Margiotta, C. Panella, E. Ierardi. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case–control studyAlimentary Pharmacology & Therapeutics 2005; 21(11): 1385 doi: 10.1111/j.1365-2036.2005.02492.x